Abuse resistant pharmaceutical formulations are provided that contain one or more abusable drugs and one or more abuse deterrent components. The abuse deterrent component(s) prevent the abusable drug(s) from being removed/extracted to an appreciable extent and/or rate. The abuse deterrent component(s) may be in the form of pellets beads beadlets granules powders or the like and may comprise a core that contains a material that is both hydrophilic and hydrophobic and optionally a pH dependent coating.
